Acquired exclusive global rights to LYL273, a novel GCC-targeted CAR T-cell product candidate that has demonstrated a 67% ...

The Head and Neck Cancer Drugs/Therapeutics Market is experiencing substantial growth, valued at USD 4.2 Billion in 2024 and ...

Neurogene Inc. , a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced positive, updated interim ...

Major clinical trial will prescribe stable dose of diazepam to drug users most at risk of overdose from street supply ...

Coffee farmers and workers are the first link in a global value chain worth hundreds of billions of dollars. With the ...

Journey Medical Corporation ( DERM) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical's Third Quarter ...

Every year, a group of Oregon health care professionals gathers for a grim exercise — reviewing every case in which a mother died during or soon after pregnancy.

Exactly. You're always first in my heart. Wayde. Wayde McMillan is the Chief Financial Officer; and Doug Bartlett, attending his first ever sell-side event of this nature, is the Senior Vice President ...

Coya Therapeutics, Inc. (Coya or the Company), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative ...

The research, conducted by scientists from the Doherty Institute, the Peter MacCallum Cancer Center, and Monash University, ...

CORONA, CA – November 10, 2025 – PRESSADVANTAGE – Moment of Clarity has published a new resource, “TMS Therapy Success Rate ...

Applied in a simple, stepwise fashion, identifying our needs and feelings while acknowledging their underlying validity, then ...